Affording Medicines for Today's Patients and Sustaining Innovation for Tomorrow

Affiliations

Comment

Kenneth C Frazier. JAMA. 2020.

. 2020 Mar 3;323(9):831-833.

doi: 10.1001/jama.2020.0167.

No abstract available

Comment on

Profitability of Large Pharmaceutical Companies Compared With Other Large Public Companies.
Ledley FD, McCoy SS, Vaughan G, Cleary EG. Ledley FD, et al. JAMA. 2020 Mar 3;323(9):834-843. doi: 10.1001/jama.2020.0442. JAMA. 2020. PMID: 32125401 Free PMC article.
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.
Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Hernandez I, et al. JAMA. 2020 Mar 3;323(9):854-862. doi: 10.1001/jama.2020.1012. JAMA. 2020. PMID: 32125403 Free PMC article.
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.
Wouters OJ, McKee M, Luyten J. Wouters OJ, et al. JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166. JAMA. 2020. PMID: 32125404 Free PMC article.